Table 5.
Percentage of women with specific opinions by use status (Nairobi)
| Attributes | Pills | Injectables | Implants | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current users | Past users | Never users | Current users | Past users | Never users | Current users | Past users | Never users | |
| Access | |||||||||
| Easy | 98.3 | 94.0 | 90.6 | 99.1 | 96.9 | 93.0 | 96.7 | 92.4 | 87.1 |
| Hard | 1.7 | 6.0 | 8.8 | 0.9 | 3.0 | 6.3 | 3.3 | 7.6 | 12.5 |
| Don’t know/unsure | 0.0 | 0.0 | 0.6 | 0.0 | 0.1 | 0.7 | 0.0 | 0.0 | 0.4 |
| Effectiveness | |||||||||
| Yes | 93.6 | 70.9 | 65.9 | 97.7 | 86.0 | 83.4 | 98.2 | 89.0 | 86.6 |
| No | 6.4 | 29.0 | 33.7 | 2.3 | 14.0 | 16.2 | 1.8 | 11.0 | 12.9 |
| Don’t know | 0.0 | 0.1 | 0.4 | 0.0 | 0.0 | 0.4 | 0.0 | 0.0 | 0.4 |
| Cause health problems | |||||||||
| Yes, serious | 5.1 | 14.2 | 12.6 | 10.6 | 23.0 | 21.1 | 9.7 | 35.5 | 24.5 |
| Yes, not serious | 18.4 | 32.7 | 28.2 | 33.4 | 38.5 | 39.4 | 31.9 | 35.9 | 37.6 |
| No | 76.5 | 52.9 | 58.4 | 55.9 | 38.5 | 38.9 | 58.5 | 28.4 | 37.2 |
| Don’t know | 0.0 | 0.2 | 0.8 | 0.1 | 0.0 | 0.6 | 0.0 | 0.2 | 0.7 |
| Interfere with menstruation | |||||||||
| Yes | 25.2 | 40.7 | 42.5 | 73.0 | 82.3 | 77.1 | 59.6 | 75.1 | 66.7 |
| No | 74.8 | 59.0 | 55.9 | 27.0 | 17.7 | 21.0 | 40.4 | 24.9 | 31.9 |
| Don’t know | 0.0 | 0.2 | 1.6 | 0.0 | 0.0 | 1.9 | 0.0 | 0.0 | 1.4 |
| Cause unpleasant side effect | |||||||||
| Yes | 30.3 | 51.4 | 47.3 | 50.6 | 65.8 | 61.7 | 44.8 | 70.9 | 60.1 |
| No | 69.7 | 48.6 | 51.9 | 49.4 | 34.2 | 37.9 | 55.2 | 28.9 | 39.5 |
| Don’t know | 0.0 | 0.0 | 0.8 | 0.0 | 0.0 | 0.4 | 0.0 | 0.2 | 0.4 |
| Unsafe to use for a long time | |||||||||
| Yes, should take a break | 46.2 | 69.2 | 74.0 | 49.0 | 70.0 | 69.0 | 37.9 | 61.6 | 61.6 |
| No, safe for long use | 53.8 | 30.8 | 25.4 | 50.9 | 29.9 | 29.8 | 61.9 | 38.4 | 37.9 |
| Don’t know | 0.0 | 0.0 | 0.7 | 0.1 | 0.2 | 1.2 | 0.2 | 0.0 | 0.5 |
| Cause infertility | |||||||||
| Yes, perhaps | 9.8 | 13.1 | 14.7 | 26.1 | 30.0 | 26.9 | 16.0 | 22.7 | 23.4 |
| No | 89.3 | 86.8 | 84.6 | 73.6 | 69.8 | 72.1 | 83.4 | 77.0 | 75.7 |
| Don’t know | 0.9 | 0.1 | 0.7 | 0.3 | 0.2 | 1.0 | 0.5 | 0.2 | 0.9 |
| FP use among friends, relatives | |||||||||
| Most | 34.2 | 26.1 | 15.3 | 72.6 | 63.0 | 52.1 | 56.3 | 46.9 | 30.8 |
| About half | 10.7 | 7.5 | 6.5 | 9.2 | 10.0 | 10.7 | 14.9 | 14.7 | 13.1 |
| Few | 45.3 | 50.6 | 54.0 | 15.2 | 22.3 | 26.9 | 25.9 | 33.0 | 44.7 |
| None | 9.8 | 15.2 | 23.5 | 2.5 | 4.2 | 9.0 | 2.7 | 4.6 | 10.8 |
| Don’t know | 0.0 | 0.6 | 0.8 | 0.4 | 0.5 | 1.3 | 0.2 | 0.7 | 0.6 |
| Experiences of friends, relatives (1) | |||||||||
| Satisfactory | 83.4 | 52 | 52.2 | 74.9 | 52.9 | 52.7 | 75.2 | 48.8 | 56 |
| Unsatisfactory | 5.2 | 27.9 | 25.3 | 4.6 | 19.3 | 20.9 | 6.6 | 25.1 | 21.9 |
| Mixed/Don’t know | 11.4 | 20.1 | 22.4 | 20.4 | 27.8 | 26.4 | 18.2 | 26.1 | 22.1 |
| Husband’s approval | |||||||||
| Approve | 92.3 | 71.8 | 55.3 | 91.5 | 77.5 | 58.4 | 90.0 | 68.5 | 53.1 |
| Disapprove | 7.69 | 28.19 | 43.82 | 8.4 | 22.4 | 39.8 | 9.8 | 31.5 | 45.7 |
| Don’t know | 0.0 | 0.0 | 0.8 | 0.1 | 0.1 | 1.8 | 0.2 | 0.0 | 1.2 |
| Satisfied with use | |||||||||
| Satisfied | 90.2 | 41.3 | – | 87.7 | 44.9 | – | 86.5 | 32.3 | – |
| Unsatisfied | 8.5 | 55.8 | – | 10.5 | 53.2 | – | 10.7 | 64.8 | – |
| Mixed/Neither | 1.3 | 2.3 | – | 1.3 | 1.3 | – | 2.0 | 2.0 | – |
| Missing | 0.0 | 0.6 | – | 0.6 | 0.6 | – | 0.7 | 1.0 | – |
| Mean net positive score (2) | 53.4 | 19.8 | 15.8 | 38.0 | 14.1 | 13.0 | 44.5 | 11.8 | 13.2 |
| Mean % of don’t know (3) | 0.1 | 0.2 | 0.8 | 0.1 | 0.1 | 1.0 | 0.1 | 0.2 | 0.7 |
| TOTAL(N) | 234 | 869 | 1684 | 909 | 1218 | 681 | 549 | 409 | 1831 |
(1) Amongst those knowing some friends were using the methods
(2) Mean percent difference between percentages of women who gave positive and negative responses among the above attributes except husband’s approval
(3) Mean percent of women who said "don’t know" to the above attributes except experiences of a method in social network and husband’s approval
Note: Chi-square test was conducted to assess associations between each of the above attributes and use status. The p-values were all 0.01 or smaller except the perceptions on risk of infertility of pills (p = 0.061) and injectables (p = 0.015)